Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. May 7, 2022; 28(17): 1830-1844
Published online May 7, 2022. doi: 10.3748/wjg.v28.i17.1830
Table 4 Disease characteristics of Crohn’s disease and ulcerative colitis
Disease characteristics
N
SA
P value (SA vs non-SA)
CDn = 174n = 35 (20.1)
Disease severity based on PCDAI score (n, column %)1
Inactive (≤ 10)17 (12.3)4 (14.3)NS
Mild (11-30)46 (33.3)9 (32.1)
Moderate-severe (> 30)75 (54.3)15 (53.6)
Disease location (n, column %)
L1 (distal 1/3 ileum +/- limited caecal disease)28 (18.7)4 (12.5)0.505 (SA)
L2 (colonic)54 (36.0)10 (31.3)
L3 (ileocolonic)62 (41.3)16 (50.0)
Isolated L4 disease6 (4.0) 2 (6.3)
L4a 59 (40.7)13 (39.4)0.973 (SA)
L4b 12 (8.3) 3 (9.1)
No L4 disease74 (51.0) 17 (51.3)
Disease behaviour (n, %)
B1 (inflammatory)136 (90.7)31 (93.9)0.858 (SA)
B2 (stricturing)5 (3.3)1 (3.0)
B3 (penetrating)8 (5.3)1 (3.0)
B2/B31 (0.7)0 (0.0)
Perianal involvement (n, %)
Perianal symptoms at presentation23 (13.2)10 (28.6)0.003 (SA)
Any form of perianal manifestation (clinical exam or imaging)53 (30.5)18 (51.4)0.003 (SA)
UCn = 119n = 33 (27.7)
Disease severity based on PUCAI score (n, column %)2
Inactive (< 10)7 (8.3)0 (0.0)0.353 (SA)
Mild (10-34)36 (42.9)11 (47.8)
Moderate (35-64)28 (33.3)9 (39.1)
Severe (≥ 65)13 (15.5)3 (13.0)
Disease location (n, column %)
E1 (proctitis)8 (7.5)2 (6.9)0.353 (SA)
E2 (left sided)16 (15.1)5 (17.2)
E3 (extensive)5 (4.7)5 (17.2)
E4 (pancolitis)77 (72.6)17 (58.6)
Disease severity (n, column %)
S0 (never severe)79 (78.2)20 (74.1)0.542 (SA)
S1 (ever severe)22 (21.8)7 (25.9)